Evidence map›Paper›PMID 37332674›Full record

ArticleiScience2023

Integrative systems biology characterizes immune-mediated neurodevelopmental changes in murine Zika virus microcephaly.

Kimino Fujimura, Amanda J Guise, Tojo Nakayama, Christoph N Schlaffner, Anais Meziani, Mukesh Kumar, Long Cheng, Dylan J Vaughan, Andrew Kodani, Simon Van Haren and 8 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Kimino FujimuraF.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Amanda J GuiseF.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Tojo NakayamaDivision of Genetics and Genomics and The Manton Center for Orphan Disease, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Christoph N SchlaffnerF.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Anais MezianiF.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Mukesh KumarF.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Long ChengF.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Dylan J VaughanDivision of Genetics and Genomics and The Manton Center for Orphan Disease, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Andrew KodaniCenter for Pediatric Neurological Disease Research and Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Simon Van HarenPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Kenneth ParkerSimulTOF Systems, Marlborough, MA, USA.
Ofer LevyPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Ann F DurbinDepartment of Microbiology, Harvard Medical School, Boston, MA, USA.
Irene BoschDepartment of Microbiology, Harvard Medical School, Boston, MA, USA.
Lee GehrkeDepartment of Microbiology, Harvard Medical School, Boston, MA, USA.
Hanno SteenPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Ganeshwaran H MochidaDivision of Genetics and Genomics and The Manton Center for Orphan Disease, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Judith A SteenF.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Boston Children's Hospital · USHarvard University · USBroad Institute · USSimulTOF Systems (United States) · USSt. Jude Children's Research Hospital · US

Funding

HUMAN EPILEPSY GENETICS--NEURONAL MIGRATION DISORDERSR01NS035129 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI WALSH, CHRISTOPHER A. · 1997 to 2023
$9.5M
Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
Virology Core: MIT Center for Human Tissue Models for Infectious Diseases (MIT.HTMID)U19AI131135 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GEHRKE, LEE · 2017 to 2021
$8.7M
Supplement request for Training GrantT32NS007473 · NINDS · CHILDREN'S HOSPITAL BOSTON · PI Elizabeth C. Engle, Thomas L. Schwarz · 1999 to 2026
$6.9M
Integrated Platform to study Neurodegeneration in Alzheimer’s DiseaseR01AG071858 · NIA · BOSTON CHILDREN'S HOSPITAL · PI STEEN, JUDITH A · 2021 to 2025
$3.9M
Proteogenomics to characterize novel non-coding and extragenic translationR01GM112007 · NIGMS · BOSTON CHILDREN'S HOSPITAL · PI KREIMAN, GABRIEL, STEEN, JUDITH A · 2015 to 2018
$2.4M
How Zika virus disrupts neuronal cellular architectureR21NS104633 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KODANI, ANDREW TADASHI, REITER, JEREMY F · 2018 to 2019
$479k
NIAID NIH HHS U19 AI131135NIA NIH HHS R01 AG071858NICHD NIH HHS P50 HD105351NIGMS NIH HHS R01 GM112007NINDS NIH HHS R01 NS035129NINDS NIH HHS R21 NS104633NINDS NIH HHS T32 NS007473
6 · The paper itself

Abstract

Characterizing perturbation of molecular pathways in congenital Zika virus (ZIKV) infection is critical for improved therapeutic approaches. Leveraging integrative systems biology, proteomics, and RNA-seq, we analyzed embryonic brain tissues from an immunocompetent, wild-type congenital ZIKV infection mouse model. ZIKV induced a robust immune response accompanied by the downregulation of critical neurodevelopmental gene programs. We identified a negative correlation between ZIKV polyprotein abundance and host cell cycle-inducing proteins. We further captured the downregulation of genes/proteins, many of which are known to be causative for human microcephaly, including Eomesodermin/T-box Brain Protein 2 (EOMES/TBR2) and Neuronal Differentiation 2 (NEUROD2). Disturbances of distinct molecular pathways in neural progenitors and post-mitotic neurons may contribute to complex brain phenotype of congenital ZIKV infection. Overall, this report on protein- and transcript-level dynamics enhances understanding of the ZIKV immunopathological landscape through characterization of fetal immune response in the developing brain.

Indexed as

Developmental neuroscienceImmunologyVirology

Identifiers

PMID37332674
PMCPMC10275723
OpenAlexW4377097012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.